Literature DB >> 6496550

Pathologic hip fractures secondary to amyloidoma. Case report and review of the literature.

K N Lai, K W Chan, D L Siu, C C Wong, D Yeung.   

Abstract

Amyloidoma primarily involving bone and lymph node is described in a 60-year-old male patient. The patient had pathologic fractures of both hips through a deposit of amyloid in the neck of the femur. The prolonged insidious course of the disease was uncomplicated by hypercalcemia, hematologic abnormalities, or renal failure so characteristic of untreated myeloma. The bone marrow contained less than 10 percent plasma cells in different stages of maturity. Radionuclide bone scanning demonstrated other osseous amyloid lesions that were not detected by routine radiologic examination. This is the first reported case of pathologic fractures of both hips secondary to amyloidoma.

Entities:  

Mesh:

Year:  1984        PMID: 6496550     DOI: 10.1016/0002-9343(84)90546-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

1.  Destructive bone lesions in primary amyloidosis.

Authors:  M R Kramer; J M van Dijk; I Hadas; C Hershko
Journal:  Postgrad Med J       Date:  1986-11       Impact factor: 2.401

2.  Case report 480: Periosteal amyloid tumor.

Authors:  S O Yoshida; R Karjoo; M R Johnstone
Journal:  Skeletal Radiol       Date:  1988       Impact factor: 2.199

Review 3.  Amyloidoma: a review and case report.

Authors:  Sohil S Desai; Michael G Rizzo; Augustus J Rush; Andrew E Rosenberg; Motasem Al Maaieh
Journal:  Skeletal Radiol       Date:  2020-07-24       Impact factor: 2.199

4.  Multiple myeloma-associated amyloidoma of the sacrum: case report and review of the literature.

Authors:  F M Klenke; C Wirtz; Y Banz; M J B Keel; N D Klass; U Novak; L M Benneker
Journal:  Global Spine J       Date:  2013-11-22

5.  Amyloidoma, an unusual cause of fracture.

Authors:  Frank Verhoeven; Clément Prati; Daniel Wendling
Journal:  Case Rep Rheumatol       Date:  2014-03-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.